Retour
Fourchette du Jour
181,00 €
184,48 €
Fourchette 52 Semaines
95,49 €
198,00 €
Volume
666 221
Moyenne 50J / 200J
173,53 €
/
144,04 €
Clôture Précédente
180,62 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -31,5 | 0,4 |
| P/B | 2,6 | 2,9 |
| ROE % | -8,5 | 3,8 |
| Net Margin % | -8,4 | 3,9 |
| Rev Growth 5Y % | 8,4 | 10,0 |
| D/E | 1,3 | 0,2 |
Objectif de Cours des Analystes
Hold
207,86 €
+14.0%
Low: 170,00 €
High: 235,00 €
P/E Prévisionnel
7,6
BPA Prévisionnel
23,93 €
Croissance BPA (est.)
+0,0%
CA Est.
4,4 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
31,98 €
30,75 € – 33,42 €
|
6 B | 2 |
| FY2029 |
30,88 €
29,69 € – 32,27 €
|
5,8 B | 2 |
| FY2028 |
26,64 €
19,61 € – 32,84 €
|
5,2 B | 4 |
Points Clés
Revenue grew 8,37% annually over 5 years — modest growth
Earnings declined -163,58% over the past year
Generating 1,30B in free cash flow
PEG of 0,18 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 3,49%
Capital efficient — spends only 1,38% of revenue on capex
Croissance
Revenue Growth (5Y)
8,37%
Revenue (1Y)4,88%
Earnings (1Y)-163,58%
FCF Growth (3Y)10,20%
Qualité
Return on Equity
-8,47%
ROIC1,73%
Net Margin-8,35%
Op. Margin5,26%
Sécurité
Debt / Equity
1,26
Current Ratio1,86
Interest Coverage1,15
Valorisation
P/E Ratio
-31,51
P/B Ratio2,60
EV/EBITDA67,98
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4,88% | Revenue Growth (3Y) | 5,50% |
| Earnings Growth (1Y) | -163,58% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 8,37% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 4,27B | Net Income (TTM) | -356,15M |
| ROE | -8,47% | ROA | -3,05% |
| Gross Margin | 88,21% | Operating Margin | 5,26% |
| Net Margin | -8,35% | Free Cash Flow (TTM) | 1,30B |
| ROIC | 1,73% | FCF Growth (3Y) | 10,20% |
| Safety | |||
| Debt / Equity | 1,26 | Current Ratio | 1,86 |
| Interest Coverage | 1,15 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -31,51 | P/B Ratio | 2,60 |
| P/S Ratio | 2,63 | PEG Ratio | 0,18 |
| EV/EBITDA | 67,98 | Dividend Yield | 0,00% |
| Market Cap | 11,22B | Enterprise Value | 15,26B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4,27B | 4,07B | 3,83B | 3,66B | 3,09B |
| Net Income | -356,15M | 560,12M | 414,83M | -224,06M | -328,95M |
| EPS (Diluted) | -5,84 | 8,65 | 6,10 | -3,58 | -5,51 |
| Gross Profit | 3,76B | 3,62B | 3,40B | 3,12B | 2,65B |
| Operating Income | 224,42M | 716,63M | 578,58M | -65,53M | 170,28M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 11,66B | 12,01B | 11,39B | 10,84B | 12,30B |
| Total Liabilities | 7,34B | 7,92B | 7,66B | 7,75B | 8,33B |
| Shareholders' Equity | 4,32B | 4,09B | 3,74B | 3,09B | 3,97B |
| Total Debt | 5,42B | 6,16B | 5,79B | 5,81B | 6,15B |
| Cash & Equivalents | 1,39B | 2,41B | 1,51B | 881,48M | 591,45M |
| Current Assets | 4,17B | 4,63B | 3,44B | 2,61B | 2,61B |
| Current Liabilities | 2,24B | 1,04B | 1,54B | 933,19M | 809,30M |